Here, we assess the role of CD44 as a marker of cancer caner stem/progenitor cells in promoting EMT and matastasis in PCa carcinogenesis, and reveal a new potential therapeutic approach to battle PCa. The gene discussed is CD44; the disease is posterior cortical atrophy.